(no title)
nickpinkston | 1 month ago
There's a billion-dollar prize if you figure this out, and the food industry is already openly discussing it.
https://www.foodnavigator.com/Article/2025/07/22/glp-1-drugs...
nickpinkston | 1 month ago
There's a billion-dollar prize if you figure this out, and the food industry is already openly discussing it.
https://www.foodnavigator.com/Article/2025/07/22/glp-1-drugs...
JumpCrisscross|1 month ago
nickpinkston|1 month ago
I'm more worried there's some plausible way (like the ginger discussed) to negate the GLP-1 agonist's function itself or its net effects.
They're not going to talk about it in open industry journals, but Big Tobacco actually did do this with engineered high nicotine tobacco used to adjust addictivity levels.
https://en.wikipedia.org/wiki/Y1_(tobacco)#Legal_controversy
dalemyers|1 month ago
Do you have any evidence of this? Your link doesn't confirm it.
nickpinkston|1 month ago
The "prize" I'm referring to isn't a literal X-Prize for addiction haha, but I mean market share, etc. is very worth investing in this.
SirFatty|1 month ago
Such insight! Of course that could be said about almost anything.
tylerrobinson|1 month ago
x______________|1 month ago
Defeated by either noscript or mobile's double-tap to select, copy.